LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

Home・Stock List・Charles River Laboratories International Inc

Charles River Laboratories International Inc

Closed

Sector Healthcare

233.12 5.25

Buy Sell

Overview

Share price change

24h

Current

Min

222.05

Max

233.69

Key metrics
By Trading Economics
Income	-120M 67M
Sales	-3.5M 1B
P/E Sector Avg	29.39 79.786
EPS	2.27
Profit margin	6.666
Employees	20,000
EBITDA	-11M 219M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+11.45 upside

Dividends
By Dow Jones
Next Earnings	7 Aug 2024

Market Stats
By TradingEconomics
Market Cap	947M 11B
Previous open	227.87
Previous close	233.12

News Sentiment

By Acuity

100%

349 / 369 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

216.97 / 227.31 Support & Resistance

Charles River Laboratories International Inc Chart

Related News

23 Mar 2024, 13:00 UTC

Peer Comparison

Price change

Charles River Laboratories International Inc Forecast

Price Target

By TipRanks

11.45% upside

12 Months Forecast

Average 247.88 USD 11.45%

High 290 USD

Low 226 USD

Based on 9 Wall Street analysts offering 12 month price targets forCharles River Laboratories International Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

Buy

Hold

Sell

Based on 9 analysts giving stock ratings to Charles River Laboratories International Inc - Dist in the past 3 months.

Technical Score

By Trading Central

216.97 / 227.31Support & Resistance

Recent bullish events outweigh bearish events.

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

349 / 369 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Charles River Laboratories International Inc

Charles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company provides products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions in research and drug development. The Company operates through two segments: Discovery and Safety Assessment (DSA) and Manufacturing Solutions (Manufacturing). The DSA segment includes services required to take a drug through the early development process including discovery services, which are non-regulated services to assist clients with the identification, screening, and selection of a lead compound for drug development, and regulated and non-regulated (Good Laboratory Practice (GLP) and non-GLP) safety assessment services. The Manufacturing segment includes Microbial Solutions, Biologics Solutions, and Avian Vaccine Services.